JOVAMCY
Live / Applied — Second extension granted (statement of use) (as of 13 Oct 2025)
What this means for you
Not registered yet, but its 09 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98491010
- Mark type
- Stylized text
- Filed
- 09 Apr 2024
- Published for opposition
- 15 Oct 2024
- Attorney of record
- Danielle Rivera
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of central nervous system diseases, peripheral neurological system diseases, and pain
Owner
- Johnson & Johnson, New Brunswick, NJ, US
- Johnson & Johnson, New Brunswick, NJ, US
Prosecution history
- 14 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Oct 2025 — SOU EXTENSION 2 GRANTED
- 13 Oct 2025 — SOU EXTENSION 2 FILED
- 13 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 02 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 May 2025 — SOU EXTENSION 1 GRANTED
- 01 May 2025 — SOU EXTENSION 1 FILED
- 01 May 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Oct 2024 — PUBLISHED FOR OPPOSITION
- 25 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Sept 2024 — ASSIGNED TO EXAMINER
- 16 Aug 2024 — TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED